Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Study to Evaluate Safety and Efficacy of TTP273 for 12 Weeks in Subjects With Type 2 Diabetes

ClinicalTrials.gov ID: NCT02653599

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT02653599. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 18, 2026, 4:58 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Parallel-Group Multi-Center Study to Evaluate the Efficacy and Safety of TTP273 Following 12 Weeks Administration in Subjects With Type 2 Diabetes Mellitus on a Stable Dose of Metformin

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This trial is a multi-center, randomized, double-blind, placebo-controlled parallel group, Phase 2 study in subjects with Type 2 diabetes mellitus on a stable dose of metformin to evaluate the safety and efficacy of TTP273 versus placebo glucose control and body weight following administration for 3 months.

Study identification

NCT ID
NCT02653599
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
vTv Therapeutics
Industry
Enrollment
174 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2015 (Type not available)
Primary completion
Nov 2016 (Actual)
Completion
Jan 2017 (Actual)
Last update posted
Feb 10, 2017

2015 – 2017

United States locations

U.S. sites
30
U.S. states
12
U.S. cities
28
Facility City State ZIP Site status
Not listed Costa Mesa California 92626 —
Not listed Encino California 91436 —
Not listed Huntington Park California 90255 —
Not listed Los Angeles California 90057 —
Not listed Oakland California 94612 —
Not listed Sacramento California 95821 —
Not listed DeLand Florida 32720 —
Not listed Miami Lakes Florida 33014 —
Not listed Port Orange Florida 32129 —
Not listed Tampa Florida 33606 —
Not listed West Palm Beach Florida 33401 —
Not listed Atlanta Georgia 30338 —
Not listed Evanston Illinois 60201 —
Not listed Flint Michigan 48504 —
Not listed Omaha Nebraska 68114 —
Not listed The Bronx New York 10459 —
Not listed Greensboro North Carolina 27408 —
Not listed High Point North Carolina 27265 —
Not listed Morehead City North Carolina 28557 —
Not listed Cincinnati Ohio 45246 —
Not listed Norman Oklahoma 73069 —
Not listed Norman Oklahoma 73072 —
Not listed Corpus Christi Texas 78413 —
Not listed Houston Texas 77074 —
Not listed Humble Texas 77338 —
Not listed Hurst Texas 76054 —
Not listed Katy Texas 77450 —
Not listed San Antonio Texas 78209 —
Not listed San Antonio Texas 78229 —
Not listed Richland Washington 99352 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02653599, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 10, 2017 · Synced Nov 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.